author index volume 171

Author Index Volume 171 (2013)

Aissaoui, A., see Drake, C.R. (171) 81Ajazuddin, Alexander, A., Khichariya, A., Gupta, S., Patel, R.J., Giri, T.K.

and Tripathi, D.K., Recent expansions in an emergent novel drugdelivery technology: Emulgel (171) 122

Akita, H., see Hossen, M.N. (171) 104Alexander, A., see Ajazuddin (171) 122Almutairi, A., see Viger, M.L. (171) 308Aluri, S., see Shi, P. (171) 330Amblard, M., see Maynadier, M. (171) 251Anchordoquy, T.J., see Betker, J.L. (171) 261Argyros, O., see Drake, C.R. (171) 81Asada, H., see Hiraishi, Y. (171) 93

Bäckman, P., see Bayard, F.J.C. (171) 234Balagna, M.A., see Mazzara, J.M. (171) 172Barakat, S., see Wada, K. (171) 33Barber, D.F., see Mejías, R. (171) 225Basile, I., see Maynadier, M. (171) 251Bayard, F.J.C., Thielemans, W., Pritchard, D.I., Paine, S.W., Young, S.S.,

Bäckman, P., Ewing, P. and Bosquillon, C., Polyethylene glycol-drug ester conjugates for prolonged retention of small inhaleddrugs in the lung (171) 234

Bhattacharyya, J., see Sinclair, S.M. (171) 38Berezin, M.Y., see Viger, M.L. (171) 308Betker, J.L., Gomez, J. and Anchordoquy, T.J., The effects of lipoplex

formulation variables on the protein corona and comparisonswith in vitro transfection efficiency (171) 261

Black, K., see Ding, H. (171) 322Bosquillon, C., see Bayard, F.J.C. (171) 234Brinkmann, U., see Hoffmann, E. (171) 48Bronich, T.K., see Desale, S.S. (171) 339Buhrman, J.S., Cook, L.C., Rayahin, J.E., Federle,M.J. and Gemeinhart, R.A.,

Proteolytically activated anti-bacterial hydrogel microspheres(171) 288

Bushman, J., Vaughan, A., Sheihet, L., Zhang, Z., Costache,M. and Kohn, J.,Functionalized nanospheres for targeted delivery of paclitaxel (171)315

Campillo-Fernández, A.J., see Seras-Franzoso, J. (171) 63Chae, J.-W., see Lim, K.S. (171) 193Charpin-El Hamri, G., see Geraths, C. (171) 57Chereddy, K.K., Coco, R., Memvanga, P.B., Ucakar, B., des Rieux, A.,

Vandermeulen, G. and Préat, V., Combined effect of PLGA andcurcumin on wound healing activity (171) 208

Chilkoti, A., see Sinclair, S.M. (171) 38Conde-Knape, K., see Hoffmann, E. (171) 48Choe, S.-w., Terman, D.S., Rivers, A.E., Rivera, J., Lottenberg, R. and

Sorg, B.S., Drug-loaded sickle cells programmed ex vivo for delayedhemolysis target hypoxic tumor microvessels and augment tumordrug delivery (171) 184

Choi, W.I., see Kim, J.-Y. (171) 113Coco, R., see Chereddy, K.K. (171) 208Cohen, S.M., see Desale, S.S. (171) 339Cook, L.C., see Buhrman, J.S. (171) 288Costache, M., see Bushman, J. (171) 315Cui, H., see Shi, P. (171) 330

Daniels-Wells, T.R., see Ding, H. (171) 322Daoud-El Baba, M., see Geraths, C. (171) 57des Rieux, A., see Chereddy, K.K. (171) 208Dengl, S., see Hoffmann, E. (171) 48Desale, S.S., Cohen, S.M., Zhao, Y., Kabanov, A.V. and Bronich, T.K.,

Biodegradable hybrid polymer micelles for combination drugtherapy in ovarian cancer (171) 339

Dhandhukia, J., see Shah, M. (171) 269Dhandhukia, J., see Shi, P. (171) 330Ding, H., Helguera, G., Rodríguez, J.A., Markman, J., Luria-Pérez, R.,

Gangalum, P., Portilla-Arias, J., Inoue, S., Daniels-Wells, T.R., Black, K.,Holler, E., Penichet, M.L. and Ljubimova, J.Y., Polymalic acidnanobioconjugate for simultaneous immunostimulation and inhibi-tion of tumor growth in HER2/neu-positive breast cancer (171) 322

Drake, C.R., Aissaoui, A., Argyros, O., Thanou, M., Steinke, J.H.G. andMiller, A.D., Examination of the effect of increasing the numberof intra-disulfide amino functional groups on the performance ofsmall molecule cyclic polyamine disulfide vectors (171) 81

Dziadek, S., see Hoffmann, E. (171) 48

Edelman, E.R., see Maslov, M.Y. (171) 201Edman, M., see Shi, P. (171) 330Edman, M.C., see Shah, M. (171) 269Elazizi, M., see Wada, K. (171) 33Elizondo, E., see Seras-Franzoso, J. (171) 63Ewing, P., see Bayard, F.J.C. (171) 234

Fang, X., see Qin, L. (171) 133Federle, M.J., see Buhrman, J.S. (171) 288Fiorellini, J.P., see Wada, K. (171) 33

Gandreuil, C., see Maynadier, M. (171) 251Gangalum, P., see Ding, H. (171) 322Gao, N., see Zhu, Z. (171) 73Garbuzenko, O.B., see Taratula, O. (171) 349Garcia, M., see Maynadier, M. (171) 251García-Celma, M.J., see Morral-Ruíz, G. (171) 163García-Fruitós, E., see Seras-Franzoso, J. (171) 63Gary-Bobo, M., see Maynadier, M. (171) 251Gemeinhart, R.A., see Buhrman, J.S. (171) 288Geraths, C., Daoud-El Baba, M., Charpin-El Hamri, G. and Weber, W., A

biohybrid hydrogel for the urate-responsive release of urateoxidase (171) 57

Journal of Controlled Release 171 (2013) e5–e8

doi:10.1016/S0168-3659(13)00776-1

Contents lists available at ScienceDirect

Journal of Controlled Release

j ourna l homepage: www.e lsev ie r.com/ locate / jconre l

Giri, T.K., see Ajazuddin (171) 122Gomez, J., see Betker, J.L. (171) 261Gooden, D.M., see Sinclair, S.M. (171) 38Gopalaswamy, R., see Sinclair, S.M. (171) 38Graves, D.T., see Wada, K. (171) 33Gujrati, M., see Malamas, A.S. (171) 296Gupta, S., see Ajazuddin (171) 122Gutiérrez, L., see Mejías, R. (171) 225

Hamm-Alvarez, S.F., see Shah, M. (171) 269Harashima, H., see Hossen, M.N. (171) 104Harashima, H., see Nakamura, T. (171) 216Hatefi, A., see Minko, T. (171) 259Helguera, G., see Ding, H. (171) 322Hernandez, J.-F., see Maynadier, M. (171) 251Hiraishi, Y., Hirobe, S., Iioka, H., Quan, Y.-S., Kamiyama, F., Asada, H.,

Okada, N. and Nakagawa, S., Development of a novel therapeuticapproach using a retinoic acid-loaded microneedle patch forseborrheic keratosis treatment and safety study in humans (171)93

Hirobe, S., see Hiraishi, Y. (171) 93Hoffmann, E., Konkar, A., Dziadek, S., Josel, H.-P., Conde-Knape, K.,

Kropp, H., Kling, L., Stubenrauch, K., Thorey, I., Dengl, S. andBrinkmann, U., PK modulation of haptenylated peptides via non-covalent antibody complexation (171) 48

Holler, E., see Ding, H. (171) 322Hossen, M.N., Kajimoto, K., Akita, H., Hyodo, M. and Harashima, H., A

comparative study between nanoparticle-targeted therapeuticsand bioconjugates as obesity medication (171) 104

Huh, K.M., see Li, L. (171) 241Hyodo, M., see Hossen, M.N. (171) 104Iioka, H., see Hiraishi, Y. (171) 93Inoue, S., see Ding, H. (171) 322

Janga, S.R., see Shah, M. (171) 269Josel, H.-P., see Hoffmann, E. (171) 48Jung, Y.-S., Park, W. and Na, K., Temperature-modulated noncovalent

interaction controllable complex for the long-term delivery ofetanercept to treat rheumatoid arthritis (171) 143

Kabanov, A.V., see Desale, S.S. (171) 339Kajimoto, K., see Hossen, M.N. (171) 104Kamiyama, F., see Hiraishi, Y. (171) 93Kang, Y.C., see Lim, K.S. (171) 193Katayama, Y., see Tang, H. (171) 178Khichariya, A., see Ajazuddin (171) 122Kim, H.A., Nam, K., Lee, M. and Kim, S.W., Hypoxia/hepatoma dual

specific suicide gene expression plasmid delivery using bio-reducible polymer for hepatocellular carcinoma therapy (171) 1

Kim, J.K., see Lim, K.S. (171) 193Kim, J.-Y., Choi, W.I., Kim, M. and Tae, G., Tumor-targeting nanogel

that can function independently for both photodynamic andphotothermal therapy and its synergy from the procedure of PDTfollowed by PTT (171) 113

Kim, M., see Kim, J.-Y. (171) 113Kim, S.-M., see Lim, K.S. (171) 193Kim, S.W., see Kim, H.A. (171) 1Kim, S.W., see Lee, Y. (171) 24Kim, Y.-H., see Lim, K.S. (171) 193Kling, L., see Hoffmann, E. (171) 48Kobayashi, H., see Tang, H. (171) 178Kohn, J., see Bushman, J. (171) 315Konkar, A., see Hoffmann, E. (171) 48Kozlovskaya, L. and Stepensky, D., Quantitative analysis of the brain-

targeted delivery of drugs and model compounds using nano-delivery systems (171) 17

Kropp, H., see Hoffmann, E. (171) 48Kummitha, C.M., see Malamas, A.S. (171) 296Kuzmov, A., see Taratula, O. (171) 349

Lázaro, F.J., see Mejías, R. (171) 225Lee, M., see Kim, H.A. (171) 1Lee, M., see Lee, Y. (171) 24Lee, Y., McGinn, A.N., Olsen, C.D., Nam, K., Lee, M., Shin, S.K. and Kim,S.W., Human erythropoietin gene delivery for cardiac remodeling of

myocardial infarction in rats (171) 24Lee, Y.-k., see Li, L. (171) 241Li, L., Nurunnabi, Md., Nafiujjaman, Md., Lee, Y.-k. and Huh, K.M.,

GSH-mediated photoactivity of pheophorbide a-conjugatedheparin/gold nanoparticle for photodynamic therapy (171) 241

Li, X., Zhao, Q. and Qiu, L., Smart ligand: Aptamer-mediated targeteddelivery of chemotherapeutic drugs and siRNA for cancer therapy(171) 152

Liang, W., see Qin, L. (171) 133Lim, K.S., Lim,M.-H.,Won, Y.-W., Kim, J.K., Kang, Y.C., Park, E.J., Chae, J.-W.,

Kim, S.-M., Ryu, S.-E., Pak, Y.K. and Kim, Y.-H., Dual-mode enhance-ment of metallothionein protein with cell transduction and retentionpeptide fusion (171) 193

Lim, M.-H., see Lim, K.S. (171) 193Lin, Y.-A., see Shi, P. (171) 330Liu, C., see Qin, L. (171) 133Liu, S., see Shah, M. (171) 269Ljubimova, J.Y., see Ding, H. (171) 322Lottenberg, R., see Choe, S.-w. (171) 184Louie, S.G., see Shah, M. (171) 269Lovich, M.A., see Maslov, M.Y. (171) 201Lu, X., see Qin, L. (171) 133Lu, Z.-R., see Malamas, A.S. (171) 296Luria-Pérez, R., see Ding, H. (171) 322

MacKay, J.A., see Shah, M. (171) 269MacKay, J.A., see Shi, P. (171) 330Malamas, A.S., Gujrati, M., Kummitha, C.M., Xu, R. and Lu, Z.-R., Design

and evaluation of new pH-sensitive amphiphilic cationic lipids forsiRNA delivery (171) 296

Markman, J., see Ding, H. (171) 322Martin, V., see Maynadier, M. (171) 251Martinez, J., see Maynadier, M. (171) 251Maslov,M.Y., Edelman, E.R.,Wei, A.E., Pezone,M.J. andLovich,M.A., High

concentrations of drug in target tissues following local controlledrelease are utilized for both drug distribution and biologic effect: Anexample with epicardial inotropic drug delivery (171) 201

Maynadier, M., Vezenkov, L.L., Amblard, M., Martin, V., Gandreuil, C.,Vaillant, O., Gary-Bobo, M., Basile, I., Hernandez, J.-F., Garcia, M.and Martinez, J., Dipeptide mimic oligomer transporter mediatesintracellular delivery of Cathepsin D inhibitors: A potential targetfor cancer therapy (171) 251

Mazzara, J.M., Balagna, M.A., Thouless, M.D. and Schwendeman, S.P.,Healing kinetics of microneedle-formed pores in PLGA films(171) 172

McDaniel, J.R., see Sinclair, S.M. (171) 38McFearin, C.L., see Viger, M.L. (171) 308McGinn, A.N., see Lee, Y. (171) 24Mejías, R., Gutiérrez, L., Salas, G., Pérez-Yagüe, S., Zotes, T.M., Lázaro, F.J.,

Morales, M.P. and Barber, D.F., Long term biotransformation andtoxicity of dimercaptosuccinic acid-coated magnetic nanoparticlessupport their use in biomedical applications (171) 225

Melgar-Lesmes, P., see Morral-Ruíz, G. (171) 163Memvanga, P.B., see Chereddy, K.K. (171) 208Miller, A.D., see Drake, C.R. (171) 81Minko, T. and Hatefi, A., Preface-tenth international nanomedicine

and drug delivery symposium (NanoDDS'12) (171) 259Minko, T., see Taratula, O. (171) 349Morales, M.P., see Mejías, R. (171) 225Mori, T., see Tang, H. (171) 178Morral-Ruíz, G., Melgar-Lesmes, P., Solans, C. and García-Celma, M.J.,

Multifunctional polyurethane–urea nanoparticles to target andarrest inflamed vascular environment: A potential tool for cancertherapy and diagnosis (171) 163

e6 Author Index Volume 171 (2013) e5-e8

Na, K., see Jung, Y.-S. (171) 143Nafiujjaman, Md., see Li, L. (171) 241Nakagawa, S., see Hiraishi, Y. (171) 93Nakamura, T., Yamazaki, D., Yamauchi, J. and Harashima, H., The

nanoparticulation by octaarginine-modified liposome improvesα-galactosylceramide-mediated antitumor therapy via systemicadministration (171) 216

Nam, K., see Kim, H.A. (171) 1Nam, K., see Lee, Y. (171) 24Niidome, T., see Tang, H. (171) 178Niidome, Y., see Tang, H. (171) 178Niu, L., see Swaminathan, S.K. (171) 280Nurunnabi, Md., see Li, L. (171) 241

Ohlfest, J.R., see Swaminathan, S.K. (171) 280Okada, N., see Hiraishi, Y. (171) 93Olsen, C.D., see Lee, Y. (171) 24Ouimet, M.A., see Wada, K. (171) 33

Paine, S.W., see Bayard, F.J.C. (171) 234Pak, Y.K., see Lim, K.S. (171) 193Pakulska, M.M., Vulic, K. and Shoichet, M.S., Affinity-based release of

chondroitinase ABC from a modified methylcellulose hydrogel(171) 11

Panyam, J., see Swaminathan, S.K. (171) 280Parera, M., see Seras-Franzoso, J. (171) 63Park, E.J., see Lim, K.S. (171) 193Park, K., PK modulation of peptides by hapten-mediated antibody

complexation (171) 91Park, K., Programmed sickle cells for targeted delivery to hypoxic

tumors (171) 258Park, W., see Jung, Y.-S. (171) 143Patel, R.J., see Ajazuddin (171) 122Penichet, M.L., see Ding, H. (171) 322Pérez-Yagüe, S., see Mejías, R. (171) 225Pezone, M.J., see Maslov, M.Y. (171) 201Portilla-Arias, J., see Ding, H. (171) 322Préat, V., see Chereddy, K.K. (171) 208Pritchard, D.I., see Bayard, F.J.C. (171) 234

Qin, L., Zhang, F., Lu, X., Wei, X., Wang, J., Fang, X., Si, D., Wang, Y.,Zhang, C., Yang, R., Liu, C. and Liang, W., Polymeric micelles forenhanced lymphatic drug delivery to treat metastatic tumors(171) 133

Qiu, L., see Li, X. (171) 152Quan, Y.-S., see Hiraishi, Y. (171) 93

Ratera, I., see Seras-Franzoso, J. (171) 63Rayahin, J.E., see Buhrman, J.S. (171) 288Rivera, J., see Choe, S.-w. (171) 184Rivers, A.E., see Choe, S.-w. (171) 184Rodgers, K., see Shah, M. (171) 269Rodríguez, J.A., see Ding, H. (171) 322Roger, E., see Swaminathan, S.K. (171) 280Roldán, M., see Seras-Franzoso, J. (171) 63Rosario-Meléndez, R., see Wada, K. (171) 33Ryu, S.-E., see Lim, K.S. (171) 193

Salas, G., see Mejías, R. (171) 225Saldaña, L., see Seras-Franzoso, J. (171) 63Schwendeman, S.P., see Mazzara, J.M. (171) 172Seras-Franzoso, J., Steurer, C., Roldán,M., Vendrell,M., Vidaurre-Agut, C.,

Tarruella, A., Saldaña, L., Vilaboa, N., Parera,M., Elizondo, E., Ratera, I.,Ventosa, N., Veciana, J., Campillo-Fernández, A.J., García-Fruitós, E.,Vázquez, E. and Villaverde, A., Functionalization of 3D scaffoldswith protein-releasing biomaterials for intracellular delivery(171) 63

Setton, L.A., see Sinclair, S.M. (171) 38

Shah,M., Edman,M.C., Janga, S.R., Shi, P., Dhandhukia, J., Liu, S., Louie, S.G.,Rodgers, K., MacKay, J.A. and Hamm-Alvarez, S.F., A rapamycin-binding protein polymer nanoparticle shows potent therapeuticactivity in suppressing autoimmunedacryoadenitis in amousemodelof Sjögren's syndrome (171) 269

Shah, M., see Shi, P. (171) 330Shah, M., see Taratula, O. (171) 349Sheihet, L., see Bushman, J. (171) 315Sheng, W., see Viger, M.L. (171) 308Shi, P., Aluri, S., Lin, Y.-A., Shah, M., Edman, M., Dhandhukia, J., Cui, H.

and MacKay, J.A., Elastin-based protein polymer nanoparticlescarrying drug at both corona and core suppress tumor growth invivo (171) 330

Shi, P., see Shah, M. (171) 269Shin, S.K., see Lee, Y. (171) 24Shoichet, M.S., see Pakulska, M.M. (171) 11Si, D., see Qin, L. (171) 133Sinclair, S.M., Bhattacharyya, J., McDaniel, J.R., Gooden, D.M.,

Gopalaswamy, R., Chilkoti, A. and Setton, L.A., A geneticallyengineered thermally responsive sustained release curcumindepot to treat neuroinflammation (171) 38

Solans, C., see Morral-Ruíz, G. (171) 163Sorg, B.S., see Choe, S.-w. (171) 184Steinke, J.H.G., see Drake, C.R. (171) 81Stepensky, D., see Kozlovskaya, L. (171) 17Steurer, C., see Seras-Franzoso, J. (171) 63Stubenrauch, K., see Hoffmann, E. (171) 48Sukhishvili, S.A., see Zhu, Z. (171) 73Swaminathan, S.K., Roger, E., Toti, U., Niu, L., Ohlfest, J.R. and Panyam, J.,

CD133-targeted paclitaxel delivery inhibits local tumor recurrencein a mouse model of breast cancer (171) 280

Tae, G., see Kim, J.-Y. (171) 113Tang, H., Kobayashi, H., Niidome, Y., Mori, T., Katayama, Y. and

Niidome, T., CW/pulsed NIR irradiation of gold nanorods:Effect on transdermal protein delivery mediated by photo-thermal ablation (171) 178

Taratula, O., Kuzmov, A., Shah, M., Garbuzenko, O.B. and Minko, T.,Nanostructured lipid carriers as multifunctional nanomedicineplatform for pulmonary co-delivery of anticancer drugs and siRNA(171) 349

Tarruella, A., see Seras-Franzoso, J. (171) 63Terman, D.S., see Choe, S.-w. (171) 184Thanou, M., see Drake, C.R. (171) 81Thielemans, W., see Bayard, F.J.C. (171) 234Thorey, I., see Hoffmann, E. (171) 48Thouless, M.D., see Mazzara, J.M. (171) 172Toti, U., see Swaminathan, S.K. (171) 280Tripathi, D.K., see Ajazuddin (171) 122

Ucakar, B., see Chereddy, K.K. (171) 208Uhrich, K.E., see Wada, K. (171) 33

Vaillant, O., see Maynadier, M. (171) 251Vandermeulen, G., see Chereddy, K.K. (171) 208Vaughan, A., see Bushman, J. (171) 315Vázquez, E., see Seras-Franzoso, J. (171) 63Veciana, J., see Seras-Franzoso, J. (171) 63Vendrell, M., see Seras-Franzoso, J. (171) 63Ventosa, N., see Seras-Franzoso, J. (171) 63Vezenkov, L.L., see Maynadier, M. (171) 251Vidaurre-Agut, C., see Seras-Franzoso, J. (171) 63Viger, M.L., Sheng, W., McFearin, C.L., Berezin, M.Y. and Almutairi, A.,

Application of time-resolved fluorescence for direct and contin-uous probing of release from polymeric delivery vehicles (171)308

Vilaboa, N., see Seras-Franzoso, J. (171) 63Villaverde, A., see Seras-Franzoso, J. (171) 63Vulic, K., see Pakulska, M.M. (171) 11

e7Author Index Volume 171 (2013) e5-e8

Wada,K., Yu,W., Elazizi,M., Barakat, S., Ouimet,M.A., Rosario-Meléndez, R.,Fiorellini, J.P., Graves, D.T. and Uhrich, K.E., Locally delivered salicylicacid from a poly(anhydride-ester): Impact on diabetic bone regenera-tion (171) 33

Wang, H., see Zhu, Z. (171) 73Wang, J., see Qin, L. (171) 133Wang, Y., see Qin, L. (171) 133Weber, W., see Geraths, C. (171) 57Wei, A.E., see Maslov, M.Y. (171) 201Wei, X., see Qin, L. (171) 133Won, Y.-W., see Lim, K.S. (171) 193

Xu, R., see Malamas, A.S. (171) 296

Yamauchi, J., see Nakamura, T. (171) 216Yamazaki, D., see Nakamura, T. (171) 216Yang, R., see Qin, L. (171) 133Young, S.S., see Bayard, F.J.C. (171) 234Yu, W., see Wada, K. (171) 33

Zhang, C., see Qin, L. (171) 133Zhang, F., see Qin, L. (171) 133Zhang, Z., see Bushman, J. (171) 315Zhao, Q., see Li, X. (171) 152Zhao, Y., see Desale, S.S. (171) 339Zhu, Z., Gao, N., Wang, H. and Sukhishvili, S.A., Temperature-triggered

on-demand drug release enabled by hydrogen-bonded multi-layers of block copolymer micelles (171) 73

Zotes, T.M., see Mejías, R. (171) 225

e8 Author Index Volume 171 (2013) e5-e8